Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

Antiviral Research

Volumn 37, Issue 2, 1998, Pages 107-120

  Sidwell, Robert W ^a   Huffman, John H ^a   Barnard, Dale L ^a   Bailey, Kevin W ^a   Wong, Min Hui ^a   Morrison, Ann ^a   Syndergaard, Timothy ^a   Kim, Choung U ^b  

^a UTAH STATE UNIVERSITY   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

Antiviral; GG167; GS4071; GS4104; Influenza virus; Neuraminidase inhibitor; Zanamivir

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; OSELTAMIVIR; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS SIALIDASE; ZANAMIVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS INHIBITION;

ACETAMIDES; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AMINES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; DOGS; ENZYME INHIBITORS; FEMALE; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; LUNG DISEASES; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; NEURAMINIDASE; OSELTAMIVIR; PYRANS; RIBAVIRIN; SIALIC ACIDS; ZANAMIVIR;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS B; RNA VIRUSES; VICTORIA;

EID: 0032007378     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00065-X     Document Type: Article

References (23)

1. Couch, R.B., Keitel, W.A., Cate, T.R., Quarles, J.A., Taber, L.A., Glezen, W.P., 1996. Prevention of influenza virus infections by current inactivated influenza virus vaccines. In: Brown, L.E., Hampson, A.W., Webster, R.G. (Eds.), Options for the Control of Influenza III. Elsevier, Amsterdam, pp. 97-106.
2. Douglas, R.G. Jr., 1990. Drug therapy. Prophylaxis and treatment of influenza. N. Engl. J. Med. 322, 443-450.
3. Eriksson, B., Helgstrand, E., Johannson, N.G., Larsson, A., Misiorny, A., Noren, J.O., Philipson, L., Stenberg, K., Stening, G., Stridh, S., Oberg, B., 1997. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob. Agents Chemother. 11, 946-951.
4. Freirich, E.J., Gehan, E.A., Roll, D.P., Schmidt, L.H., Skipper, H.E., 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rept. 50, 219-244.
5. Hayden, F.G., Couch, R.B., 1992. Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimantadine. Rev. Med. Virol. 2, 89-96.
6. Hayden, F.G., Rollins, B.S., 1997. In vitro activity of the neuraminidase inhibitor GS4071 against influenza viruses. Antiviral Res. 34, A86. Proceedings of the 10th International Conference on Antiviral Research, Abstract 159.
7. Hayden, F.G., Rollins, B.S., Madren, L.K., 1994. Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Antiviral Res. 25, 123-131.
8. Hayden, F.G., Treanor, J.J., Betts, R.F., Lobo, M., Esinhart, J.D., Hussey, E.K., 1996. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 275, 295-299.
9. Huffman, J.H., Sidwell, R.W., Barnard, D.L., Morrison, A., Otto, M.J., Hill, C.F., Schinazi, R.F., 1997. Influenza virus-inhibitory effects of a series of germanium and silicon-centred polyoxometalates. Antiviral Chem. Chemother. 8, 75-83.
10. Judd, A.K., Sanchez, A., Bucher, D.J., Huffman, J.H., Bailey, K., Sidwell, R.W., 1997. In vivo anti-influenza virus activity of a zinc finger peptide. Antimicrob. Agents Chemother. 41, 687-692.
11. Kim, C.U., Lew, W., Williams, M.A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M.S., Mendel, D.B., Tai, C.Y., Laver, W.G., Stevens, R.C., 1997. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119, 681-690.
12. Li, W.-X., Escarpe, P.A., Chen, M.S., Lew, W., Williams, M.A., Zhang, L., Kim, C.U., Bischofberger, N., Cundy, K.C., Eisenberg, E.J., Mendel, D.B., 1997. GS4104 is a highly bioavailable prodrug of the novel, potent influenza neuraminidase inhibitor GS4071. Antiviral Res. 34, A74. Proceedings of the 10th International Conference on Antiviral Research, Abstract 112.
13. Mendel, D.B., Tai, C.Y., Escarpe, P.A., Li, W.-X., Kim, C.U., Williams, M.A., Lew, W., Zhang, L., Bischofberger, N., Huffman, J.H., Sidwell, R.W., Chen, M.S., 1997. GS4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro. Antiviral Res. 34, A73. Proceedings of the 10th International Conference on Antiviral Research, Abstract 111.
14. Oxford, J.S., 1976. Specific inhibitors of influenza virus replication as potential chemotherapeutic agents. J. Antimicrob. Chemother. 1, 7-23.
15. Palese, P., Compans, R.W., 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2, 3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33, 159-163.
16. Ryan, D.M., Ticehurst, J., Dempsey, M.H., Penn, C.R., 1994. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38, 2270-2275.
17. Ryan, D.M., Ticehurst, J., Dempsey, M.H., 1995. GG167 (4-guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents Chemother. 39, 2583-2584.
18. Sidwell, R.W., Huffman, J.H., Call, E.W., Alaghamandaan, H., Cook, P.D., Robins, R.K., 1986. Effect of selenazofurin on influenza A and B virus infections of mice. Antiviral Res. 6, 343-353.
19. Sidwell, R.W., Huffman, J.H., Gilbert, J., Moscon, B., Pedersen, G., Burger, R., Warren, R.P., 1992. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrob. Agents Chemother. 36, 473-476.
20. Thomas, G.P., Forsyth, M., Penn, C.R., McCauley, J.W., 1994. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid. Antiviral Res. 24, 351-356.
21. Von Itzstein, M., Wu, W.-Y., Kok, G.B., Pegg, M.S., Dayson, J.C., Phan, T.V., Smythe, M.L., White, H.F., Oliver, S.W., Colman, P.M., Vanghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R., 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
22. Von Itzstein, M., Yang, M.W., Jin, B., 1994. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydrate Res. 259, 301-305.
23. Woods, J.M., Bethell, R.C., Coates, J.A.V., Healy, N., Hiscox, S.A., Pearson, B.A., Ryan, D.M., Ticehurst, J., Tilling, J., Walcott, S.A., Penn, C.R., 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-Ar-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37, 1473-1479.